Benzinga | Aug 10, 2020 04:01PM EDT

Adverum Biotechnologies Q2 EPS $(0.36) Misses $(0.28) Estimate

Adverum Biotechnologies (NASDAQ:ADVM) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.28) by 28.57 percent. This is a 56.52 percent decrease over losses of $(0.23) per share from the same period last year.